mitomycin has been researched along with Uveal Effusion Syndrome in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Uveal Effusion Syndrome: Rare disease characterized by suprachoroidal fluid accumulation between the CHOROID and the SCLERA, annular detachment of the CHOROID, often with secondary RETINAL DETACHMENT; OPTIC DISK EDEMA, and minimal signs of UVEITIS and INTRAOCULAR PRESSURE changes.
Excerpt | Relevance | Reference |
---|---|---|
"To describe the use of topical mitomycin-C in sclerostomy revision for recalcitrant idiopathic uveal effusion syndrome." | 8.02 | APPLICATION OF ADJUNCTIVE TOPICAL MITOMYCIN-C IN SCLEROSTOMY REVISION FOR REFRACTORY IDIOPATHIC UVEAL EFFUSION SYNDROME. ( Ali, MH; Chang, PY; Haq, Z; Mieler, WF; Zahid, S; Zhu, I, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Zhu, I | 1 |
Haq, Z | 1 |
Ali, MH | 1 |
Chang, PY | 1 |
Zahid, S | 1 |
Mieler, WF | 1 |
1 other study available for mitomycin and Uveal Effusion Syndrome
Article | Year |
---|---|
APPLICATION OF ADJUNCTIVE TOPICAL MITOMYCIN-C IN SCLEROSTOMY REVISION FOR REFRACTORY IDIOPATHIC UVEAL EFFUSION SYNDROME.
Topics: Administration, Topical; Humans; Male; Middle Aged; Mitomycin; Sclerostomy; Treatment Outcome; Uveal | 2021 |